The GP IIb/IIIa Inhibitor Abciximab (ReoPro((R))) Decreases Activation and Interaction of Platelets and Leukocytes During In Vitro Cardiopulmonary Bypass Simulation
The aim of this study was to investigate the effect of the GP IIb/IIIa inhibitor abciximab (ReoPro((R))) on the function and interaction of platelets and leukocytes during experimental CPB.
1 min read